actos side effects actos news consumer lawyers attorneys fees contact us
Actos Lawsuit
Actos News
U.S. Supreme Court
33⅓% Contingent Fee
Contact Us
Our lawyers are investigating claims against Takeda for serious side effects associated with Actos. Follow the latest news on lawsuits against the manufacturer of Actos. Read about how our landmark U.S. Supreme Court victory benefited consumers across America. Many law firms charge percentage fees as high as 45%. We charge 33⅓% and we're paid only if we win your case and you collect. If you or a loved one has suffered side effects after taking Actos, contact us to discuss your legal rights.

Actos News
 

We have compiled the latest news on actos. If you or a loved one has suffered side effects after taking Actos and you would like more information about your legal rights, please contact us.

Attorney for Actos Patients Encourages Users to Consult Their Physicians About Alternative Drugs O'Steen & Harrison, PLC
November 3, 2011

Phoenix Attorney Jonathan O’Steen is encouraging all users of the type 2 diabetes drug Actos (pioglitazone) to consult their physicians about the advisability of switching to other effective drugs that do not pose the serious risks that have been associated with Actos. O’Steen’s law firm, O’Steen & Harrison, represents patients who have been diagnosed with bladder cancer and previously had taken Actos.

 
Actos Diabetes Treatments Raise Risk of Eye Disease, Study Finds Bloomberg
June 24, 2011

Takeda Pharmaceutical Co.'s Actos, the world's best-selling diabetes treatment, and GlaxoSmithKline Plc. (GSK)'s Avandia raise the risk of an eye disease that can lead to blindness, a study shows.

People taking the drugs have a 3 to 6 times increased risk of developing diabetic macular edema, a condition in which the retina thickens and swells, according to a study of more than 100,000 people to be presented Sunday at the American Diabetes Association's annual meeting in San Diego.

 
FDA: Long-Term Use of Actos Increases Cancer Risk American Pharmacists Association
June 21, 2011

FDA recently issued a drug safety communication warning patients and health professionals that use of pioglitazone (Actos—Takeda) for more than 1 year may be associated with an increased risk of bladder cancer. This information will be added to the Warnings and Precautions section of the drug label and to the patient Medication Guide for all drugs containing pioglitazone.

 
 
FDA Warns of Bladder Cancer Risk ABC News
June 16, 2011

Patients taking the diabetes drug Actos for more than a year may have an increased risk of bladder cancer, according to an FDA interim review of an ongoing epidemiological study.

The warning comes just days after two European countries banned use of the drug. The European Medicines Agency (EMA) has yet to release any guidance on use of Actos.

americas highest rated law firms

O'Steen & Harrison, PLC

300 W. Clarendon Ave., Suite 400
Phoenix, Arizona 85013-3424

800.883.8888
info@vanosteen.com

Your Legal Rights

If you or a loved one has been harmed as a result of Actos, you may be entitled to compensation.

You should act immediately to contact a lawyer experienced in matters involving dangerous pharmaceuticals.

Contact Us
Name
Phone
Email